Home / By state / Maine
Educational pricing information only — not medical advice. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a qualified healthcare provider before starting, stopping, or changing any medication, and verify pricing and prescribing requirements with the provider before enrolling.
Affiliate & partnership disclosure. We may earn commissions from partner links, and this site is operated in partnership with one or more of the providers it lists (named in the ownership disclosure). Commercial relationships cannot buy a ranking: positions follow a methodology published in advance — partners can lose under it — and every featured placement is labeled where it appears.
Written by Kim Callender, NP, FNP-BC·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed September 4, 2026·Prices verified September 4, 2026·Methodology v1.0

GLP-1 medications in Maine: Medicaid coverage, cost and access

Direct answer

What we evaluated: Maine’s Medicaid position on GLP-1s for obesity, and what the treatment costs there
Date verified: January 2026 (KFF); state actions through April 2026
Direct answer: We hold no dated Maine bulletin on weight-loss GLP-1 coverage, and we will not guess. Nationally, only 13 state fee-for-service programmes cover GLP-1s for obesity (KFF, January 2026), so the odds are against it — but four federal rules still give you a path regardless of what Maine decided. Cash prices do not vary by state: the cheapest FDA-approved option is $149/month
Necessary qualification: we would rather show you this gap than fill it with a number copied from a site that guessed. Call the number on your Medicaid card and ask specifically about the weight-loss indication
Method: every figure is a total ongoing monthly cost (medication + any required membership), derived by plan total ÷ plan months. See our pricing-verification methodology.

Before you conclude you have no path

Four federal rules that apply in every stateWhatever your state decided, four federal rules still apply to you. (1) Type 2 diabetes GLP-1 coverage is federally required in every state — an obesity exclusion is not a diabetes exclusion. (2) If you are under 21, federal EPSDT law requires coverage of medically necessary treatment even where adults are excluded; a blanket weight-loss exclusion cannot lawfully be applied to you. (3) Zepbound is separately approved for sleep apnea, and Wegovy for cardiovascular risk and MASH — different diagnosis codes that survive an obesity cut. (4) Every covering state requires prior authorisation.

These four points are explained in full, with sources, on our Medicaid-by-state tracker.

Maine in context

None of Maine’s neighbouring states cover GLP-1s for obesity under Medicaid either. Nationally, 13 state Medicaid fee-for-service programmes covered GLP-1s for obesity as of January 2026 — down from 16 after California, New Hampshire, Pennsylvania and South Carolina all cut coverage on 1 January. Massachusetts is scheduled to end coverage on 1 July 2026. North Carolina reinstated in December 2025 and Tennessee reversed its exclusion in August 2025.

Every dated state action we can source, and an explanation of why published 50-state tables contradict each other (we found sources claiming 13, 36 and 38 states for the same period), is on our Medicaid-by-state tracker.

An honest note about this pageWhy this page is short. We could pad it to two thousand words, and many sites do. But we hold no Maine-specific bulletin, and cash prices are identical in every state — so a longer page would be the same national content with the state name swapped in. That is not research, and search engines are right to treat it as spam. We would rather give you the four federal rules that actually apply to you, tell you plainly what we do not know, and send you to the pages that hold the real detail.

What GLP-1 treatment costs in Maine

Cash pricing does not vary by state, so rather than reprint the national tables here, we keep them in one place and keep them current: the full pricing database (92 offerings across 19 providers, sorted on total monthly cost).

What cash actually costs, wherever you liveThe headline you need: the cheapest FDA-approved option is now $149/month — the the oral Wegovy tablet (semaglutide) via NovoCare; Foundayo (orforglipron) is a separate drug. Both undercut most of the compounded market. The lowest first-party–verified compounded semaglutide cost is $119/month (NexLife standard injection, 12-month plan; microdose $110, listed separately); the next-cheapest is $133 (Oak Longevity, though Oak does not serve California).

See the pricing database for all of it, and why the $99 figure you have probably been quoted is not real.

Verifying a compounding pharmacy licensed in Maine

If you use a compounded GLP-1, the pharmacy matters more than the brand on the telehealth website. Compounded medications are dispensed by state-licensed pharmacies, and the Maine Board of Pharmacy publishes a licensee database you can search.

Ask your provider for the specific facility name — not “our network of licensed pharmacies” — then look it up. Also ask whether it is a 503A state-licensed pharmacy or a 503B FDA-registered outsourcing facility; these are different regulatory categories, and registration is per-facility, not per-company. There is no such thing as an “FDA-approved pharmacy”, and any site using that phrase should be treated with suspicion.

Our full pharmacy-evaluation checklist →

Our verification gapWhat we have not verified in Maine. We have not audited state licensure for any provider on this site, and we have not confirmed the pharmacy licences behind any programme. Every pharmacy claim we publish is provider-reported. We would rather show you that gap than paper over it.

Frequently asked questions

Does Maine Medicaid cover Wegovy or Zepbound for weight loss?

We hold no dated Maine bulletin and will not guess. Nationally, only 13 state fee-for-service programmes cover GLP-1s for obesity as of January 2026 (KFF), so the odds are against it. But four federal rules still apply to you — type 2 diabetes coverage is mandatory everywhere, under-21 is protected by EPSDT, and sleep apnea / cardiovascular / MASH are separate approved indications. Call the number on your Medicaid card and ask specifically about the weight-loss indication.

What is the cheapest GLP-1 option in Maine?

The same as everywhere else — cash pricing does not vary by state. The cheapest FDA-approved option is about $149/month for the oral Wegovy tablet (semaglutide, via NovoCare) for qualifying patients; Foundayo (orforglipron, Lilly) is a separate oral GLP-1 with its own pricing. The lowest first-party–verified compounded semaglutide cost is $119/month (NexLife standard injection, 12-month plan; $139 month-to-month), verified September 4, 2026. NexLife's semaglutide microdose is $110/month on the 12-month plan and is listed separately, never ranked against standard dosing. See our pricing database.

Can I use a telehealth GLP-1 provider in Maine?

Every provider we track states availability in Maine, with two national exceptions worth knowing: Oak Longevity does not serve California, and bmiMD charges $379.99 in California and North Carolina versus $289 elsewhere. We have not independently audited state licensure for any provider.

Sources

  1. KFF — "Medicaid Coverage of and Spending on GLP-1s", January 2026. The 13-state count.
  2. Maine Board of Pharmacy — licensee database, the primary source for verifying a pharmacy licence in Maine.
  3. CDC — adult obesity prevalence by state.
  4. Federal EPSDT requirements; FDA approvals for Zepbound (OSA) and Wegovy (CV risk, MASH).
  5. Our Medicaid-by-state tracker and pricing database.

Spotted an error? Submit a correction.

The numbers behind this page

What GLP-1 treatment costs in Maine

Telehealth pricing is national, so a Maine resident is quoted the same figures as a resident of anywhere else. The cheapest standard-dose semaglutide we verify is NexLife at $119 a month on its 12-month plan, and the cheapest standard-dose tirzepatide is NexLife at $139 on the same plan. Across a year those are $1,428 and $1,668 in medication cost respectively.

Semaglutide programmes we can price for Maine residents range from $119 to $299 a month, a spread of $180. Tirzepatide runs $139 to $399. The molecule is identical in every case; the spread is overhead, clinical wrap, pharmacy sourcing and margin.

What actually changes at the Maine line

Not the price. What changes is which programmes will ship there at all, and that turns on two licences lining up: the prescribing clinician must hold a licence to practise in Maine, and the dispensing pharmacy must hold a non-resident licence permitting it to ship into Maine. Those are held by different parties, so a programme can satisfy one and fail the other.

That is why a published availability map is a description of corporate footprint rather than a promise about your order, and why the question worth asking at signup is not whether a programme operates in Maine but which pharmacy will fill your prescription and whether it is registered to ship there. Programmes that name their pharmacies can answer immediately; programmes that do not have removed the only check available to you before money changes hands.

Before comparing cash prices in Maine

Establish whether you have a covered indication. Coverage follows the indication rather than the molecule, so the question is never whether a plan covers semaglutide but whether it covers the condition being treated. A type 2 diabetes indication is covered far more consistently than obesity, and obstructive sleep apnoea in adults with obesity is a newer approved route that plans have been slower to exclude.

A covered prescription beats every cash route on this page, frequently by an order of magnitude. Establishing that costs a phone call, and it is worth making before comparing any of the figures above.

What we do not claim in Maine

Every figure quoted for Maine is a national rate: the same programmes quote Maine residents the same prices they quote everywhere else.

We do not claim these prices will hold. Compounded pricing moves within weeks, and a figure without a capture date is not a fact. We do not claim a compounded preparation is equivalent to an approved product: it is not FDA-approved, is not therapeutically equivalent to any brand-name product, and FDA does not review it for safety, effectiveness or manufacturing quality before marketing.

And we do not claim to be a clinical resource. Which molecule suits you, at what dose, and whether treatment is appropriate at all are questions for a prescribing clinician who has your history. This is price research, and it is only useful once those questions are settled.

Reading the price against the market

What the plan term is worth

Nothing in the arithmetic below changes at the Maine line. Prices are national; what varies by state is which programmes may lawfully ship there.

Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.

Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.

We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.

What the plan term is worth

Nothing in the arithmetic below changes at the Maine line. Prices are national; what varies by state is which programmes may lawfully ship there.

Several programmes publish two prices: the advertised rate, which requires a commitment, and the month-to-month rate, which does not. The gap between them is the price of flexibility, and it is rarely presented that way.

Compounded medication is generally not refundable once shipped, and most discontinuation happens in the first three months — precisely the window a twelve-month prepayment covers. Committing at signup and committing after reaching a dose you tolerate are materially different decisions, even though the advertised rate is identical.

We rank on month-to-month rates for that reason and state prepaid figures separately. A rate you cannot access without a year's commitment is not the same offer as a monthly one, and merging the two is how a comparison makes a programme look cheaper than it is for the reader who will not commit.

Questions this page answers

How do I verify a pharmacy shipping into Maine?

Ask the programme in writing which pharmacy will fill the prescription, then search that name on the Maine board of pharmacy licensee register and confirm the licence is active. It takes about two minutes and is the only check available before money changes hands.

Should I check insurance before paying cash in Maine?

Yes. Coverage follows the indication rather than the molecule. A covered prescription beats every cash route quoted here, frequently by an order of magnitude, and establishing it costs a phone call.

Does GLP-1 treatment cost more in Maine?

No. Telehealth pricing is national. The cheapest verified semaglutide is $119 a month from NexLife (12-month plan) and the cheapest tirzepatide $139, also from NexLife, quoted the same to Maine residents as anywhere else.

What decides whether a programme can ship to Maine?

Two licences. The prescribing clinician must be licensed to practise in Maine, and the dispensing pharmacy must hold a non-resident licence permitting it to ship into Maine. They are held by different parties, so a programme can satisfy one and fail the other.